35kDa Hyaluronan Fragment Treatment of Colorectal and Rectal Cancer
HA35 (Bioactive HA or B-HA or HA35) have good tissue permeability (B-HA injection, Ministry of Health, Registration number L20200708MP07707). HA35 might not lose HA's bioactivities of binding to a variety of hyaluronan's binding proteins or receptors, including the analgesic and anticancer effects of hyaluronan, therefore being named bioactive HA or B-HA (10) (B-HA injection, Ministry of Health, Registration number L20200708MP07707).
Our Features
Discover the distinct features of our Diabetes Study Trial. Each element symbolizes a unique aspect of our approach, balancing patient care, scientific integrity, and innovation. Explore these carefully curated features that make the very foundation of our commitment to improve health care.
Patient Monitoring
We prioritize participant health with continuous, personalized monitoring to keep track of progress and ensure a secure trial journey.
Experimental Medications
Our trials often involve the testing of novel medications aimed at improving diabetes management & potentially providing innovative solutions.
Genetic Understanding
Understanding genetics plays a crucial part in our trial, helping to unveil individual responsiveness to treatments and uncovering potential groundbreaking paths.
Regular Check-ups
Rigorous health assessments are a hallmark of our study. Regular check-ups guarantee participant well-being and accurate data collection.
Disease Resistance
We examine how diabetes interacts with other ailments, especially immune responses. This aids in comprehensive treatment approaches.
Post-Trial Care
Every participant's post-trial wellbeing is crucial. We ensure seamless transition and support even after the trial concludes.
Testimonials
Every participant's post-trial wellbeing is crucial. We ensure seamless transition and support even after the trial concludes
“This trial gave me hope. The team's constant support and commitment to my well-being truly motivated me to contribute to diabetes research.”
Jane Cooper
CEO & Co-Founder - XYZ Inc.
“Being a part of this study enriched my understanding about diabetes. Their transparent communication and high standards of care greatly reassured me.”
Brooklyn Simmons
CEO & Co-Founder - XYZ Inc.
“I am grateful for my participation. I felt cared for, comprehended the dynamics of my condition better, and saw the potential for aspiring changes.”
Esther Howards
CEO & Co-Founder - XYZ Inc.
Check your eligibility
Take up this questionnaire to help us determine if you have symptoms that are common to this clinical study. if you have the common symptoms, you may be eligible to take part in the study.
How it works?
Understanding the process of our clinical trials is easy. We have broken it down into streamlined steps, ensuring that participants can embark on this journey with transparency and ease.
1
Receiving the medication
You would receive entanercept (Enbrel) twice a week for 12 weeks and then once a week for 12 weeks. Etanercept as well as study related medical care is provided at no cost.
2
Visiting the study site
Study participation involves approximately 8 visits to your
local study center over 6 to 7 months.
3
Follow-up
There would also be a follow-up telephone call 30 days after
completing the study. No visits are required after participation
is complete.
A Modern and Smart Approach to Clinical Trials Research
We fuse digital technology and scientific innovation, creating a modern, smart approach to streamline and enhance clinical trials research.
Frequently Asked Questions
Regarding our clinical study, we understand you may have questions. To aid clarity, we've compiled some frequently asked queries.
What is a clinical trial?
+
-
A clinical trial is a research study analyzing the effectiveness and safety of medical interventions like new drugs, devices, or treatments. It involves rigorously controlled tests on volunteer participants, providing valuable data that contribute to improving health outcomes, advancing medicine, and influencing future standards of care.
What is the purpose of this study?
+
-
The purpose of this study is to evaluate the potential of new treatments or preventive approaches in managing a specific health condition. The insights gathered from the trials could revolutionize the future of healthcare, paving the way for safer, more effective medical interventions.
What are the risk of study participation?
+
-
Every clinical trial involves some level of uncertainty. However, be reassured that your safety is our primary concern - risks are minimized through rigorous protocols, and any potential side effects will be communicated transparently. Regular health check-ups and continuous monitoring aid careful management of your wellbeing.
What is a placebo?
+
-
A placebo is an inert substance resembling the test drug but contains no active ingredients. It's used as a control in clinical trials to compare the effectiveness of the new treatment in comparison to no treatment, thus ensuring the authenticity of the results.